Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1978 Apr 1;147(4):1078–1088. doi: 10.1084/jem.147.4.1078

Acute phase reactants ceruloplasmin and haptoglobin and their relationship to plasma prostaglandins in rabbits bearing the VS2 carcinoma

PMCID: PMC2184254  PMID: 650152

Abstract

Results of previous studies have shown that the VX2 carcinoma in rabbits synthesizes large amounts of prostaglandin E2 (PGE2). PGE2 secreted by the tumor is rapidly metabolized and can be measured in plasma as the metabolite 13,14-dihydro-15-keto-PGE2 (PGE2-M). We have previously proposed that the hypercalcemia that occurs in rabbits bearing the VX2 carcinoma is due to excessive secretion of PGE2 by the tumor and its subsequent action on the skeleton as a bone resorption- stimulating factor. In the course of these studies, we noted that the plasma of rabbits bearing the VS2 carcinoma became blue about 1 wk after tumor implantation. The intensity of the color increased markedly thereafter. We therefore measured ceruloplasmin in plasma by both chemical and immunological assay methods. Plasma ceruloplasmin and PGE2- M rose in parallel (within 7-10 days) and preceded by 7-10 days the development of hypercalcemia. 2 wk after tumor implantation, plasma PGE2-M and ceruloplasmin had risen about 20- and 6-fold, respectively, while the rise in plasma calcium was just beginning. Indomethacin, an inhibitor of prostaglandin synthesis, given from the time of tumor implantation prevented completely the hypercalcemia and largely inhibited the rise in ceruloplasmin. When given after hyperprostaglandinemia had developed, indomethacin produced a fall in both PGE2-M and ceruloplasmin. A rise in plasma haptoglobin concentrations similar to that seen for ceruloplasmin was also observed. No changes in plasma albumin concentrations occurred. We conclude that the acute phase reactants ceruloplasmin and haptoglobin rise rapidly in the plasma of rabbits bearing the VX2 carcinoma, and that this increase is related to arachidonic acid metabolism in these animals. It is possible that arachidonic acid metabolites also play a role in the elevations of these two plasma proteins observed in certain patients with malignant tumors.

Full Text

The Full Text of this article is available as a PDF (686.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armstrong D. T., Grinwich D. L. Blockade of spontaneous and LH-induced ovulation in rats by indomethacin, an inhibitor of prostaglandin biosynthesis. I. Prostaglandins. 1972 Jan;1(1):21–28. doi: 10.1016/0090-6980(72)90062-7. [DOI] [PubMed] [Google Scholar]
  2. Demers L. M., Allegra J. C., Harvey H. A., Lipton A., Luderer J. R., Mortel R., Brenner D. E. Plasma prostaglandins in hypercalcemic patients with neoplastic disease. Cancer. 1977 Apr;39(4):1559–1562. doi: 10.1002/1097-0142(197704)39:4<1559::aid-cncr2820390430>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  3. Flower R. J. Drugs which inhibit prostaglandin biosynthesis. Pharmacol Rev. 1974 Mar;26(1):33–67. [PubMed] [Google Scholar]
  4. Franklin R. B., Tashjian A. H., Jr Intravenous infusion of prostaglandin E2 raises plasma calcium concentration in the rat. Endocrinology. 1975 Jul;97(1):240–243. doi: 10.1210/endo-97-1-240. [DOI] [PubMed] [Google Scholar]
  5. Frieden E., Hsieh H. S. Ceruloplasmin: the copper transport protein with essential oxidase activity. Adv Enzymol Relat Areas Mol Biol. 1976;44:187–236. doi: 10.1002/9780470122891.ch6. [DOI] [PubMed] [Google Scholar]
  6. Humes J. L., Bonney R. J., Pelus L., Dahlgren M. E., Sadowski S. J., Kuehl F. A., Jr, Davies P. Macrophages synthesis and release prostaglandins in response to inflammatory stimuli. Nature. 1977 Sep 8;269(5624):149–151. doi: 10.1038/269149a0. [DOI] [PubMed] [Google Scholar]
  7. Klein D. C., Raisz L. G. Prostaglandins: stimulation of bone resorption in tissue culture. Endocrinology. 1970 Jun;86(6):1436–1440. doi: 10.1210/endo-86-6-1436. [DOI] [PubMed] [Google Scholar]
  8. Laurell C. B. Electroimmuno assay. Scand J Clin Lab Invest Suppl. 1972;124:21–37. doi: 10.3109/00365517209102748. [DOI] [PubMed] [Google Scholar]
  9. Laurell C. B. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem. 1966 Apr;15(1):45–52. doi: 10.1016/0003-2697(66)90246-6. [DOI] [PubMed] [Google Scholar]
  10. Levine L., Hinkle P. M., Voelkel E. F., Tashjian A. H., Jr Prostaglandin production by mouse fibrosarcoma cells in culture: inhibition by indomethacin and aspirin. Biochem Biophys Res Commun. 1972 May 26;47(4):888–896. doi: 10.1016/0006-291x(72)90576-1. [DOI] [PubMed] [Google Scholar]
  11. Levine L. Levels of 13,14-dihydro-15-keto-PGE2 in some biological fluids as measured by radioimmunoassay. Prostaglandins. 1977;14(6):1125–1139. doi: 10.1016/0090-6980(77)90290-8. [DOI] [PubMed] [Google Scholar]
  12. Robertson R. P., Baylink D. J., Metz S. A., Cummings K. B. Plasma prostaglandin E in patients with cancer with and without hypercalcemia. J Clin Endocrinol Metab. 1976 Dec;43(6):1330–1335. doi: 10.1210/jcem-43-6-1330. [DOI] [PubMed] [Google Scholar]
  13. Samuelsson B., Granström E., Green K., Hamberg M., Hammarström S. Prostaglandins. Annu Rev Biochem. 1975;44:669–695. doi: 10.1146/annurev.bi.44.070175.003321. [DOI] [PubMed] [Google Scholar]
  14. Seyberth H. W., Hubbard W. C., Oelz O., Sweetman B. J., Watson J. T., Oates J. A. Prostaglandin-mediated hypercalcemia in the VX2 carcinoma-bearing rabbit. Prostaglandins. 1977 Aug;14(2):319–331. doi: 10.1016/0090-6980(77)90177-0. [DOI] [PubMed] [Google Scholar]
  15. Seyberth H. W., Segre G. V., Morgan J. L., Sweetman B. J., Potts J. T., Jr, Oates J. A. Prostaglandins as mediators of hypercalcemia associated with certain types of cancer. N Engl J Med. 1975 Dec 18;293(25):1278–1283. doi: 10.1056/NEJM197512182932502. [DOI] [PubMed] [Google Scholar]
  16. Shim B. S. Increase in serum haptoglobin stimulated by prostaglandins. Nature. 1976 Jan 29;259(5541):326–327. doi: 10.1038/259326a0. [DOI] [PubMed] [Google Scholar]
  17. Sunderman F. W., Jr, Nomoto S. Measurement of human serum ceruloplasmin by its p-phenylenediamine oxidase activity. Clin Chem. 1970 Nov;16(11):903–910. [PubMed] [Google Scholar]
  18. Tashjian A. H., Jr, Voelkel E. F., Goldhaber P., Levine L. Prostaglandins, calcium metabolism and cancer. Fed Proc. 1974 Jan;33(1):81–86. [PubMed] [Google Scholar]
  19. Tashjian A. H., Jr, Voelkel E. F., Goldhaber P., Levine L. Successful treatment of hypercalcemia by indomethacin in mice bearing a prostaglandin-producing fibrosarcoma. Prostaglandins. 1973 Apr;3(4):515–524. doi: 10.1016/0090-6980(73)90161-5. [DOI] [PubMed] [Google Scholar]
  20. Tashjian A. H., Jr, Voelkel E. F., Levine L. Effects of hydrocortisone on the hypercalcemia and plasma levels of 13,14-dihydro-15-keto-prostaglandin E2 in mice bearing the HSDM1 fibrosarcoma. Biochem Biophys Res Commun. 1977 Jan 10;74(1):199–207. doi: 10.1016/0006-291x(77)91394-8. [DOI] [PubMed] [Google Scholar]
  21. Tashjian A. H., Jr, Voelkel E. F., Levine L., Goldhaber P. Evidence that the bone resorption-stimulating factor produced by mouse fibrosarcoma cells is prostaglandin E 2 . A new model for the hypercalcemia of cancer. J Exp Med. 1972 Dec 1;136(6):1329–1343. doi: 10.1084/jem.136.6.1329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Tashjian A. H., Jr, Voelkel E. F., Levine L. Plasma concentrations of 13,14-dihydro-15-keto-prostaglandin E2 in rabbits bearing the VX2 carcinoma: effects of hydrocortisone and indomethacin. Prostaglandins. 1977 Aug;14(2):309–317. doi: 10.1016/0090-6980(77)90176-9. [DOI] [PubMed] [Google Scholar]
  23. Tashjian A. H., Jr, Voelkel E. F., McDonough J., Levine L. Hydrocortisone inhibits prostaglandin production by mouse fibrosarcoma cells. Nature. 1975 Dec 25;258(5537):739–741. doi: 10.1038/258739a0. [DOI] [PubMed] [Google Scholar]
  24. Vane J. R. Prostaglandins as mediators of inflammation. Adv Prostaglandin Thromboxane Res. 1976;2:791–801. [PubMed] [Google Scholar]
  25. Voelkel E. F., Tashjian A. H., Jr, Franklin R., Wasserman E., Levine L. Hypercalcemia and tumor-prostaglandins: the VX2 carcinoma model in the rabbit. Metabolism. 1975 Aug;24(8):973–986. doi: 10.1016/0026-0495(75)90089-x. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES